What happens after 6 months By the 6-month mark, most users who have maintained treatment report substantially improved energy compared to their pre-treatment baseline
Events of dysesthesia and urinary tract infections were generally mild to moderate, the majority resolved during treatment, and most participants continued taking retatrutide
If you have questions about GLP-1 medications, weight loss treatment, or how emerging therapies like retatrutide might affect your options in the future, our clinical team is here to help
Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines
The medication targets receptors in your brain that play a role in regulating hunger and satiety
Other possible causes include: Sleep apnea Thyroid disorders Certain medications Infections Anxiety and stress Other medical conditions A comprehensive evaluation can help identify the true cause